stockrowSTERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
- Revenue
- +8.79%
- EPS
- +12.8%
- Free cash flow
- +43.6%
- Total debt
- −0.21%
Quarter to September 2026, against a year earlier
Follow STE
Alert me
STERIS plc (STE) Current ratio
STERIS plc's current ratio at the end of the quarter to 30 September 2026 was 2.1×, down 0.0× from fiscal 2026 (2.1×). Over the past ten years it has ranged from 2.0× (fiscal 2025) to 3.1× (fiscal 2024); the current reading is higher than 25% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2026 | 2.1× | 6.85% |
| FY2025 | 2.0× | (36.48%) |
| FY2024 | 3.1× | 32.02% |
| FY2023 | 2.3× | 14.55% |
| FY2022 | 2.0× | (2.83%) |
| FY2021 | 2.1× | (13.73%) |
| FY2020 | 2.4× | 7.30% |
| FY2019 | 2.3× | (8.80%) |
| FY2018 | 2.5× | (6.88%) |
| FY2017 | 2.7× | 9.87% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 2.1× | 7.70% |
| Jun 2026 | 1.9× | (8.87%) |
| Mar 2026 | 2.1× | (15.63%) |
| Dec 2025 | 2.5× | 4.61% |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| PEN Penumbra, Inc. compare | 5.9× |
| GKOS Glaukos Corporation compare | 4.6× |
| GMED Globus Medical, Inc. compare | 4.3× |
| SNN Smith & Nephew SNATS, Inc. compare | 2.1× |
| STE STERIS plc | 2.1× |
| DXCM DexCom, Inc. compare | 1.7× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 1.5× |
| PHG Koninklijke Philips N.V. compare | 1.3× |
| GEHC GE HealthCare Technologies Inc. compare | 1.3× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement